Breaking: India's API Manufacturing Set to Transform Global Drug Landscape
The Indian Active Pharmaceutical Ingredients (API) manufacturing sector is on the verge of a significant transformation, with market projections placing its value at approximately USD 12.0 billion by 2035. This growth trajectory, representing a compound annual growth rate (CAGR) of 8.50%, is fueled by the country’s robust capabilities in bulk drug manufacturing and its pivotal role as a...
0 Σχόλια 0 Μοιράστηκε 388 Views 0 Προεπισκόπηση
social art-inpa https://social.art-inpa.com